Clinical trial
Combination Chemotherapy in Treating Patients With Stage I, II, or IIIA…
NCT00003053 · European Institute of Oncology, Other · Unknown status
Key facts
| NCT number | NCT00003053 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Stage I, II, or IIIA Non-small Cell Lung Cancer That Has Been Surgically Removed |
| Official title | Adjuvant Treatment of Non Small Cell Lung Cancer |
| Lead sponsor | European Institute of Oncology, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug, Procedure |
| Interventions | cisplatin, etoposide, adjuvant therapy |
| Enrollment | 750 |
| Start date | Jan 1, 1994 |
| First posted | Jan 27, 2003 |
| Last update posted | Sep 20, 2013 |
| Countries | Greece, Italy, South Korea |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: